Organization: Health Canada
Year: 2022
Month: June
Request Number: A-2021-002114
Request Summary: The screening acceptance letter(s) from Health Canada to any and all generic drug manufacturer(s) for any and all abbreviated new drug submissions (ANDS) for the following medicinal ingredients which appear on the list of Generic Drug Submissions under review dated March 15, 2022: atorvastatin, levetiracetam, ticagrelor.
Disposition: Disclosed in part
Number of pages: 9